ArticleZeitschrift fur Rheumatologie2026
Adult-onset Still's disease in an 83-year-old patient with positive antinuclear antibodies: a case report.
Article in Zeitschrift fur Rheumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adult-onset Still's disease (AOSD) is a rare, systemic autoinflammatory disorder predominantly affecting young adults. It is characterized by polyarthritis, systemic inflammation with high spiking fevers, a transient salmon-pink rash, hepatosplenomegaly, and elevated ferritin levels. Its clinical presentation is highly heterogeneous and lacks specificity, and there are currently no unified diagnostic criteria. Differential diagnosis requires the exclusion of infections, malignancies, other rheumatic diseases, and adverse drug reactions. We report the case of a woman in her 80s in whom the diagnosis of adult-onset Still's disease was delayed owing to her advanced age, atypical rash, and positive antinuclear antibody status, despite significantly elevated serum ferritin levels. This case highlights that AOSD can affect older individuals, including those aged ≥ 80 years, and should be considered in the differential diagnosis of these patients when presenting with unexplained fever, especially if accompanied by rashes and hyperferritinemia. Moreover, a positive antinuclear antibody test does not rule out the diagnosis of AOSD. Timely and appropriate treatment can improve the prognosis of older patients with adult-onset Still's disease.
Indexed as
Identifiers
42714582What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.